Current Location:Home > Company news

On April 8, founder Dr. Chen Huimin participated in the finals of the third

Source:SinoBioPrint (Shanghai) Biotech Ltd.Editor:adminVisit:747Time:2023-04-12

0
图片

  Since the third "Haiju Talents" Global Innovation and Entrepreneurship Competition was launched on August 3, 2022, there have been two overseas and domestic competitions. Overseas divisions include the United States, the United Kingdom, Germany, Australia and Singapore. The domestic division includes Beijing, Shanghai, Jiangsu, Zhejiang and Shenzhen. At the same time, the competition also set up "innovation" and "entrepreneurship" two courses. This competition collected a total of 8118 entries from around the world. Through the preliminary and rematch of each division, a total of 80 entries advanced to the finals.

图片

图片

  Dr. Chen Huimin, the founder and CEO of Huaxia Siyin (Shanghai) Biotechnology Co., Ltd. participated in the "Haiju Talents" Global Innovation and Entrepreneurship Competition on behalf of the company. She performed well in the preliminary and final rounds and successfully advanced to the finals.

图片

图片

 From April 8 to 9, 2023, the final of the third "Haiju Talents" Global Innovation and Entrepreneurship Competition was held in Shanghai Zhangjiang Science Hall. Many talent roadshow projects focused on scientific and technological innovation, facing the world's scientific and technological frontier. Starting from the major strategic needs of the country, there were many technological breakthroughs and achievements in biomedicine, high-tech materials, chip technology, intelligent manufacturing and other aspects.

图片

图片

 In this fierce competition, Huaxia Siyin showed outstanding innovation ability and technical strength. Dr. Huimin Chen said, "We are very proud to have made it to the final of the 'Haiju Talents' Global Innovation and Entrepreneurship Competition. This competition is an affirmation of our technological innovation capabilities, and also encourages us to continue to provide Chinese solutions for cartilage regeneration and repair. We believe it will bring benefits to more patients."

图片

图片

  Huaxia Siyin focuses on the clinical transformation of biological 3D printing in the fields of sports medicine, orthopedics and plastic surgery. Adhering to the values of "focus, excellence and universal benefit", the company is striving forward in the biological 3D printing technology platform and the innovative medical equipment circuit, contributing to the construction of a healthy China. Look forward to working with upstream and downstream companies, investment and financing companies in a wider range, deeper fields and higher level. Welcome to contact and exchange.